Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 11—November 2018
Research

Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo

Michel Kaswa KayomoComments to Author , Epco Hasker, Muriel Aloni, Léontine Nkuku, Marcel Kazadi, Thierry Kabengele, Dorcas Muteteke, François Kapita, Alphonse Lufulwabo, Ya Diul Mukadi, Jean-Jacques Muyembe-Tamfum, Margareta Ieven, Bouke C. de Jong, and Marleen Boelaert
Author affiliations: Institute of Tropical Medicine, Antwerp, Belgium (M.K. Kayomo, E. Hasker, B.C. de Jong, M. Boelaert); National Tuberculosis Program, Kinshasa, Democratic Republic of the Congo (M.K. Kayomo, M. Aloni, M. Kazadi, T. Kabengele, D. Muteteke, F. Kapita, A. Lufulwabo); Institut National de Recherche Biomédicale, Kinshasa (M.K. Kayomo, M. Aloni, L. Nkuku, J.-J. Muyembe-Tamfum); Université de Kinshasa, Kinshasa (M.K. Kayomo, M. Aloni, J.-J. Muyembe-Tamfum); US Agency for International Development, Washington, DC, USA (Y.D. Mukadi); University of Antwerp, Antwerp (M. Ieven)

Main Article

Figure 2

Number of new TB cases registered per quarter, Mbuji-Mayi Central Prison, Democratic Republic of the Congo, 2008–2015. TB cases include bacteriologically positive and clinically diagnosed TB patients. Clinical diagnosis was based on >1 TB-related sign or symptom, a chest radiograph abnormality consistent with TB infection, or both. During 2008–2014, bacteriologic confirmation was based on microscopic results from sputum samples collected through passive case-finding. Xpert MTB/RIF was introdu

Figure 2. Number of new TB cases registered per quarter, Mbuji-Mayi Central Prison, Democratic Republic of the Congo, 2008–2015. TB cases include bacteriologically positive and clinically diagnosed TB patients. Clinical diagnosis was based on >1 TB-related sign or symptom, a chest radiograph abnormality consistent with TB infection, or both. During 2008–2014, bacteriologic confirmation was based on microscopic results from sputum samples collected through passive case-finding. Xpert MTB/RIF was introduced during the last quarter of 2014. Source: Democratic Republic of Congo National TB Program. Q, quarter; TB, tuberculosis.

Main Article

Page created: October 17, 2018
Page updated: October 17, 2018
Page reviewed: October 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external